Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

During the Trading Day
5.56 -0.34 / -5.76%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.60 +0.04 / +0.72%
 
Volume: 149.4K

Today’s Trading

Previous close5.90
Today’s open5.94
Day’s range5.54 - 5.99
Volume5,136,119
Average volume (3 months)6,668,148
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-3.76%
Earnings growth (this year)+40.94%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-19.87%
P/E ratioNM
Price/Sales11.14
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.55-4.35%
FGENFibroGen Inc-0.91-3.87%
ARIAARIAD Pharmaceutical...+0.02+0.26%
NKTRNektar Therapeutics-0.29-2.54%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$25.1M
Annual profit (last year)-$268.5M
Net profit margin-1,069.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers